| Mascolini M, Boucher CA, Mellors JW, et al.
Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. [Journal Article]
Antivir Ther 2009; 14(7):1015-37.
Abstract | Full Citation | | Vaz P, Chaix ML, Jani I, et al.
Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]
Pediatr Infect Dis J 2009 Nov 10.
Abstract | Full Citation | | Marcelin AG, Flandre P, Descamps D, et al.
Factors associated with virological response to etravirine in non nucleoside reverse transcriptase inhibitor experienced HIV-1 infected patients. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Nov 9.
Abstract | Full Citation | Find Related Articles | | Minuto JJ, Haubrich R
Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection. [JOURNAL ARTICLE]
Futur HIV Ther 2008 Nov 1; 2(6):525-537.
Abstract | Full Citation | Find Related Articles | | Quaranta S, Woloch C, Paccou A, et al.
Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Oct 27.
Abstract | Full Citation | Find Related Articles | | Grennan JT, Walmsley S
Etravirine for HIV-1: Addressing the Limitations of the Nonnucleoside Reverse Transcriptase Inhibitor Class. [JOURNAL ARTICLE]
J Int Assoc Physicians AIDS Care (Chic Ill) 2009 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | De Mendoza C, Garrido C, Poveda E, et al.
Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain. [Journal Article]
AIDS Res Hum Retroviruses 2009 Oct; 25(10):967-72.
Abstract | Full Citation | | Iwata M, Fujii H, Yoshida S, et al.
Pharmacological and clinical profile of Etravirine (Intelence((R))). [Journal Article]
Nippon Yakurigaku Zasshi 2009 Oct; 134(4):225-31.
Full Citation | Publisher Full Text | Find Related Articles | | Loutfy M, Ribera E, Florence E, et al.
Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 14.
Full Citation | | Thuret I, Chaix ML, Tamalet C, et al.
Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS 2009 Nov 13; 23(17):2364-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
